Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of... – Method of regulating cell metabolism or physiology
Patent
1998-12-17
1999-11-16
LeGuyader, John L.
Chemistry: molecular biology and microbiology
Animal cell, per se ; composition thereof; process of...
Method of regulating cell metabolism or physiology
435 6, 435 911, 435366, 536 231, 536 2431, 536 2433, 536 245, C07H 2104, C12Q 168, C12N 1585
Patent
active
059856645
ABSTRACT:
Antisense compounds, compositions and methods are provided for modulating the expression of Sentrin. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding Sentrin. Methods of using these compounds for modulation of Sentrin expression and for treatment of diseases associated with expression of Sentrin are provided.
REFERENCES:
Boddy et al., PIC 1, a novel ubiquitin-like protein which interacts with the PML component of a multiprotein complex that is disrupted in acute promyelocytic leukaemia, Oncogene, 1996, 13:971-982.
Gong et al., Preferential interaction of sentrin with a ubiquitin-conjugating enzyme, Ubc9, J. Biol. Chem., 1997, 272:28198-28201.
Mahajan et al., A small ubiquitin-related polypeptide involved in targeting RanGAP1 to nuclear pore complex protein RanBP2, Cell, 1997, 88:97-107.
Okura et al., Protection against Fas/APO-1- and tumor necrosis factor-mediated cell death by a novel protein, sentrin, J. Immunol., 1996, 157:4277-4281.
Schwarz et al., The ubiquitin-like proteins SMT3 and SUMO-1 are conjugated by the UBC9 E2 enzyme, Proc. Natl. Acad. Sci. U S A, 1998, 95:560-564.
Shen et al., UBL1, a human ubiquitin-like protein associating with human RAD51/RAD52 proteins, Genomics, 1996, 36:271-279.
Sternsdorf et al., Evidence for covalent modification of the nuclear dot-assoicated proteins PML and Sp100 by PIC1/SUMO-1, J. Cell Biol., 1997, 139:1621-1634.
Baker Brenda F.
Cowsert Lex M.
ISIS Pharmaceuticals Inc.
LeGuyader John L.
Licata Jane Massey
Schmidt Melissa
LandOfFree
Antisense modulation of Sentrin expression does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antisense modulation of Sentrin expression, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antisense modulation of Sentrin expression will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1323707